Associated Papers
Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.
Prenen H et al.
Oncotarget, 2015
26474454 (PubMed )
Supplement: oncotarget-06-36418-s001.pdf
Select a paper to view details